Novartis AG
SIX:NOVN

Watchlist Manager

Novartis AG

SIX:NOVN

Watchlist

Dividends

Price: 92.61 CHF 0.72% Market Closed

Market Cap: 181.2B CHF

Have any thoughts about
Novartis AG?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 92.61 CHF

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

NOVN Alert

Novartis AG

92.61

+0.66 (+0.72%)

52 Week Range	80.2138 102.7
Price Target

We'll email you a reminder when the closing price reaches CHF.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Novartis AG

What unique competitive advantages
does Novartis AG hold over its rivals?

What risks and challenges
does Novartis AG face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Novartis AG.

What unique competitive advantages
does Novartis AG hold over its rivals?

What risks and challenges
does Novartis AG face in the near future?

Has there been any significant insider trading activity
in Novartis AG recently?

Summarize the latest earnings call
of Novartis AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novartis AG.

Provide P/S
for Novartis AG.

Provide P/E
for Novartis AG.

Provide P/OCF
for Novartis AG.

Provide P/FCFE
for Novartis AG.

Provide P/B
for Novartis AG.

Provide EV/S
for Novartis AG.

Provide EV/GP
for Novartis AG.

Provide EV/EBITDA
for Novartis AG.

Provide EV/EBIT
for Novartis AG.

Provide EV/OCF
for Novartis AG.

Provide EV/FCFF
for Novartis AG.

Provide EV/IC
for Novartis AG.

Show me price targets
for Novartis AG made by professional analysts.

What are the Revenue projections
for Novartis AG?

How accurate were the past Revenue estimates
for Novartis AG?

What are the Net Income projections
for Novartis AG?

How accurate were the past Net Income estimates
for Novartis AG?

What are the EPS projections
for Novartis AG?

How accurate were the past EPS estimates
for Novartis AG?

What are the EBIT projections
for Novartis AG?

How accurate were the past EBIT estimates
for Novartis AG?

Compare the revenue forecasts
for Novartis AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novartis AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novartis AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novartis AG compared to its peers.

Compare the P/E ratios
of Novartis AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Novartis AG with its peers.

Analyze the financial leverage
of Novartis AG compared to its main competitors.

Show all profitability ratios
for Novartis AG.

Provide ROE
for Novartis AG.

Provide ROA
for Novartis AG.

Provide ROIC
for Novartis AG.

Provide ROCE
for Novartis AG.

Provide Gross Margin
for Novartis AG.

Provide Operating Margin
for Novartis AG.

Provide Net Margin
for Novartis AG.

Provide FCF Margin
for Novartis AG.

Show all solvency ratios
for Novartis AG.

Provide D/E Ratio
for Novartis AG.

Provide D/A Ratio
for Novartis AG.

Provide Interest Coverage Ratio
for Novartis AG.

Provide Altman Z-Score Ratio
for Novartis AG.

Provide Quick Ratio
for Novartis AG.

Provide Current Ratio
for Novartis AG.

Provide Cash Ratio
for Novartis AG.

What is the historical Revenue growth
over the last 5 years for Novartis AG?

What is the historical Net Income growth
over the last 5 years for Novartis AG?

What is the current Free Cash Flow
of Novartis AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novartis AG.

EV/EBIT
Enterprise Value to EBIT

14.9

Current

13.7

Median

17.2

Industry

Higher than median

Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT

14.9

Enterprise Value

189.2B CHF

EBIT

14.4B USD

All Countries

Forward Multiples

			Market Cap	EV/EBIT
CH		Novartis AG SIX:NOVN	181.2B CHF	14.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-5 046 864.6
US		Eli Lilly and Co NYSE:LLY	756.5B USD	54.2
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	17 702.3
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	27.8
US		Johnson & Johnson NYSE:JNJ	364.1B USD	15.6
US		Merck & Co Inc NYSE:MRK	248.4B USD	12.4
CH		Roche Holding AG SIX:ROG	208.5B CHF	12.1
UK		AstraZeneca PLC LSE:AZN	159.6B GBP	253.8
IE	E	Endo International PLC LSE:0Y5F	146B USD	587.7
US		Pfizer Inc NYSE:PFE	150.1B USD	15.9

				EBIT Growth
CH		Novartis AG SIX:NOVN	Average EV/EBIT: 1 869.7 14.9	54%
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -5 046 864.6	N/A
US		Eli Lilly and Co NYSE:LLY	54.2	212%
UK		Dechra Pharmaceuticals PLC LSE:DPH	17 702.3	675%
DK		Novo Nordisk A/S CSE:NOVO B	27.8	85%
US		Johnson & Johnson NYSE:JNJ	15.6	29%
US		Merck & Co Inc NYSE:MRK	12.4	695%
CH		Roche Holding AG SIX:ROG	12.1	27%
UK		AstraZeneca PLC LSE:AZN	253.8	131%
IE	E	Endo International PLC LSE:0Y5F	587.7	N/A
US		Pfizer Inc NYSE:PFE	15.9	63%

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBIT

12.2

2-Years Forward

EV/EBIT

11.5

3-Years Forward

EV/EBIT

Novartis AG
SIX:NOVN

EV/EBIT
Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Novartis AG SIX:NOVN

EV/EBIT Enterprise Value to EBIT

EV/EBIT Forward Multiples

See Also

Company

Help

Tools

Stocks

Novartis AG
SIX:NOVN

EV/EBIT
Enterprise Value to EBIT